Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1999 1
2000 1
2002 3
2004 2
2005 1
2006 1
2007 2
2008 3
2011 1
2012 1
2013 2
2014 3
2015 1
2017 1
2019 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials.
Scholtz AW, Waldfahrer F, Hampel R, Weisshaar G. Scholtz AW, et al. Clin Drug Investig. 2022 Sep;42(9):705-720. doi: 10.1007/s40261-022-01184-0. Epub 2022 Jul 21. Clin Drug Investig. 2022. PMID: 35864302 Free PMC article.
The main objective was to further evaluate the efficacy and safety of the fixed combination of cinnarizine 20 mg and dimenhydrinate 40 mg in comparison to various other antivertigo treatments in patients suffering from central and/or peripheral vestibular vertigo. . …
The main objective was to further evaluate the efficacy and safety of the fixed combination of cinnarizine 20 mg and dimenhydrinate 4 …
Comparison of cinnarizine/dimenhydrinate fixed combination with the respective monotherapies for vertigo of various origins: a randomized, double-blind, active-controlled, multicentre study.
Hahn A, Novotný M, Shotekov PM, Cirek Z, Bognar-Steinberg I, Baumann W. Hahn A, et al. Clin Drug Investig. 2011;31(6):371-83. doi: 10.2165/11588920-000000000-00000. Clin Drug Investig. 2011. PMID: 21401214 Clinical Trial.
The aim of this study was to compare the efficacy and tolerability of a fixed combination of the peripherally acting cinnarizine (20 mg) plus the centrally acting dimenhydrinate (40 mg) with those of equally dosed monotherapies in the treatment of vertigo of various …
The aim of this study was to compare the efficacy and tolerability of a fixed combination of the peripherally acting cinnarizine (20 mg) plu …
Treatment of vertigo due to acute unilateral vestibular loss with a fixed combination of cinnarizine and dimenhydrinate: a double-blind, randomized, parallel-group clinical study.
Scholtz AW, Schwarz M, Baumann W, Kleinfeldt D, Scholtz HJ. Scholtz AW, et al. Clin Ther. 2004 Jun;26(6):866-77. doi: 10.1016/s0149-2918(04)90130-0. Clin Ther. 2004. PMID: 15262457 Clinical Trial.
Patients are frequently confined to bed rest but may continue to experience vertigo symptoms. A well-established antivertiginous therapy consisting of cinnarizine and dimenhydrinate at low doses may offer rapid relief of acute vertigo symptoms due to acute ve …
Patients are frequently confined to bed rest but may continue to experience vertigo symptoms. A well-established antivertiginous ther …
Intravenous Lorazepam versus dimenhydrinate for treatment of vertigo in the emergency department: a randomized clinical trial.
Marill KA, Walsh MJ, Nelson BK. Marill KA, et al. Ann Emerg Med. 2000 Oct;36(4):310-9. doi: 10.1067/mem.2000.110580. Ann Emerg Med. 2000. PMID: 11020677 Clinical Trial.
STUDY OBJECTIVE: To determine whether lorazepam is more effective than dimenhydrinate in relieving the symptom of vertigo in the emergency department setting. ...Dimenhydrinate appears to be the preferred medicine for patients who present to the ED with ve …
STUDY OBJECTIVE: To determine whether lorazepam is more effective than dimenhydrinate in relieving the symptom of vertigo in t …
Comparison of the therapeutic efficacy of intravenous dimenhydrinate and intravenous piracetam in patients with vertigo: a randomised clinical trial.
Doğan NÖ, Avcu N, Yaka E, Yılmaz S, Pekdemir M. Doğan NÖ, et al. Emerg Med J. 2015 Jul;32(7):520-4. doi: 10.1136/emermed-2014-204006. Epub 2014 Jul 22. Emerg Med J. 2015. PMID: 25052217 Clinical Trial.
BACKGROUND: The present study aimed to compare the therapeutic efficacy of dimenhydrinate and piracetam in patients with vertigo. METHODS: A blinded, parallel group, superiority, randomised clinical trial was carried out on patients who presented to the emergency de …
BACKGROUND: The present study aimed to compare the therapeutic efficacy of dimenhydrinate and piracetam in patients with vertigo …
Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
Pytel J, Nagy G, Tóth A, Spellenberg S, Schwarz M, Répassy G. Pytel J, et al. Clin Ther. 2007 Jan;29(1):84-98. doi: 10.1016/j.clinthera.2007.01.010. Clin Ther. 2007. PMID: 17379049 Clinical Trial.
OBJECTIVE: This study was conducted to evaluate the efficacy and tolerability of a fixed low-dose combination of cinnarizine 20 mg + dimenhydrinate 40 mg in the treatment of vertigo of central, peripheral, or combined central/peripheral origin. ...CONCLUSIONS: In th …
OBJECTIVE: This study was conducted to evaluate the efficacy and tolerability of a fixed low-dose combination of cinnarizine 20 mg + dime …
Comparison of the effectiveness of intravenous piracetam and intravenous dimenhydrinate in the treatment of acute peripheral vertigo in the emergency department.
Ozdemir H, Akinci E, Coskun F. Ozdemir H, et al. Singapore Med J. 2013 Nov;54(11):649-52. doi: 10.11622/smedj.2013225. Singapore Med J. 2013. PMID: 24276103 Free article. Clinical Trial.
INTRODUCTION: We aimed to compare the effectiveness of intravenous piracetam with that of intravenous dimenhydrinate in the treatment of acute peripheral vertigo in the emergency department. ...We conclude that piracetam, which has fewer side effects than dimenhy …
INTRODUCTION: We aimed to compare the effectiveness of intravenous piracetam with that of intravenous dimenhydrinate in the treatment …
A fixed combination of cinnarizine/dimenhydrinate for the treatment of patients with acute vertigo due to vestibular disorders : a randomized, reference-controlled clinical study.
Hahn A, Sejna I, Stefflova B, Schwarz M, Baumann W. Hahn A, et al. Clin Drug Investig. 2008;28(2):89-99. doi: 10.2165/00044011-200828020-00003. Clin Drug Investig. 2008. PMID: 18211117 Clinical Trial.
BACKGROUND AND OBJECTIVE: Vestibular dysfunction commonly leads to - often severe - vertigo symptoms. The objective of this study was to compare the antivertiginous efficacy and tolerability of a fixed combination of cinnarizine/dimenhydrinate with those of betahist …
BACKGROUND AND OBJECTIVE: Vestibular dysfunction commonly leads to - often severe - vertigo symptoms. The objective of this study was …
Transdermally administered scopolamine vs. dimenhydrinate. I. Effect on nausea and vertigo in experimentally induced motion sickness.
Pyykkö I, Schalén L, Jäntti V. Pyykkö I, et al. Acta Otolaryngol. 1985 May-Jun;99(5-6):588-96. doi: 10.3109/00016488509182265. Acta Otolaryngol. 1985. PMID: 4024909 Clinical Trial.
Dimenhydrinate was somewhat more effective against nausea than one TTS-scopolamine. Vertigo was significantly reduced after dimenhydrinate and two TTS-scopolamine. ...
Dimenhydrinate was somewhat more effective against nausea than one TTS-scopolamine. Vertigo was significantly reduced after …
Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial.
Scholtz AW, Hahn A, Stefflova B, Medzhidieva D, Ryazantsev SV, Paschinin A, Kunelskaya N, Schumacher K, Weisshaar G. Scholtz AW, et al. Clin Drug Investig. 2019 Nov;39(11):1045-1056. doi: 10.1007/s40261-019-00858-6. Clin Drug Investig. 2019. PMID: 31571128 Free PMC article. Clinical Trial.
The objective of the present study was to evaluate whether the fixed combination of cinnarizine and dimenhydrinate (Arlevert()) is non-inferior and thus a potentially useful alternative to betahistine dihydrochloride in the treatment of patients suffering from peripheral v …
The objective of the present study was to evaluate whether the fixed combination of cinnarizine and dimenhydrinate (Arlevert()) is no …
24 results